SCHEMBL30768447

SCHEMBL30768447

Oc1ccc(C(c2c[nH]c3ncc(Br)cc23)c2c[nH]c3ncc(Br)cc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.55
DYRK1A Q13627 10/20 0.46
PLK4 O00444 1/20 0.46
AURKA O14965 1/20 0.46
JAK2 O60674 1/20 0.46
ROCK2 O75116 1/20 0.46
PRKD3 O94806 1/20 0.46
MAP4K4 O95819 1/20 0.46
PRKCG P05129 1/20 0.46
INSR P06213 1/20 0.46
CDK1 P06493 1/20 0.46
FES P07332 1/20 0.46
IGF1R P08069 1/20 0.46
ROS1 P08922 1/20 0.46
FGFR1 P11362 1/20 0.46
PHKG2 P15735 1/20 0.46
FER P16591 1/20 0.46
FLT1 P17948 1/20 0.46
CDK2 P24941 1/20 0.46
MARK3 P27448 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26696374 1.00 GUSB (0.55) GUSBDYRK1APLK4AURKAJAK2
SCHEMBL26696369 0.83 GUSB (0.46) GUSBDYRK1AJAK2DYRK1BCLK1
SCHEMBL30768376 0.83 GUSB (0.46) GUSBDYRK1AJAK2DYRK1BCLK1
SCHEMBL26696363 0.80 MTNR1A (0.44) GUSBDYRK1ADYRK1BCLK1DYRK2
SCHEMBL30768400 0.80 MTNR1A (0.44) GUSBDYRK1ADYRK1BCLK1DYRK2
SCHEMBL13138395 0.78 DYRK1A (0.43) GUSBDYRK1APLK4AURKAJAK2
SCHEMBL26873386 0.75 CDC7 (0.47) GUSBPDPK1
SCHEMBL30768359 0.75 CDC7 (0.47) GUSBPDPK1
SCHEMBL1516629 0.75 DYRK1A (0.73) DYRK1APLK4AURKAJAK2ROCK2
SCHEMBL30039498 0.75 GUSB (0.89) GUSBMGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382926-A1 COMPOUNDS AND USES THEREOF THE UNIVERSITY OF THE WEST INDIES (TT) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382926-A1 COMPOUNDS AND USES THEREOF CFTR, CCL11, CEL GUSB 111/4885DYRK1A 4777/4885PLK4 3266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.